Alexandra M Mowday (Alexsandra Mowday)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Molecular diagnosis & therapy

Cancer gene therapy

Pharmaceuticals (Basel, Switzerland)

Cancers

Maastricht University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Maastricht University Jun 01 2018

Netherlands

Postdoctoral Research Fellow :: Precision Medicine

Publications

Jan Theys, Adam V Patterson, Alexandra M Mowday
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery. Molecular diagnosis & therapy 28 (2) (2024)
Jan Theys, Adam V Patterson, Alexandra M Mowday
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery. Molecular diagnosis & therapy 28 (2) (2024)
Jan Theys, Adam V Patterson, Alexandra M Mowday
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery. Molecular diagnosis & therapy (2024)
Jan Theys, Adam V Patterson, Alexandra M Mowday
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery. Molecular diagnosis & therapy 28 (2) (2024)
Aleksandra M Kubiak, Jella van de Laak, Yanchao Zhang, Tom S Bailey, Luuk Claessen, Philip Hittmeyer, Carlijn Vlaswinkel, Alexandra M Mowday, Ludwig J Dubois, Jan Theys
Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments? Future microbiology (2023)
Amir Ashoorzadeh, Alexandra M Mowday, Maria R Abbattista, Christopher P Guise, Matthew R Bull, Shevan Silva, Adam V Patterson, Jeff B Smaill
Design and Biological Evaluation of Piperazine-Bearing Nitrobenzamide Hypoxia/GDEPT Prodrugs: The Discovery of CP-506. ACS medicinal chemistry letters 14 (11) (2023)
Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, Shevan Silva, Matthew R Bull, Maria R Abbattista, Janine N Copp, Elsie M Williams, David F Ackerley, Adam V Patterson, Jeff B Smaill
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, Ala Yaromina, Emily Liu, Damiënne Marcus, Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Xiaojing Lin, Zhe Fu, Sisira Kumara, Arthur Jochems, Amir Ashoorzadeh, Robert F Anderson, Kevin O Hicks, Matthew R Bull, Maria R Abbattista, Christopher P Guise, Sofie Deschoemaeker, Sophie Thiolloy, Arne Heyerick, Morwena J Solivio, Silvia Balbo, Jeff B Smaill, Jan Theys, Ludwig J Dubois, Adam V Patterson, Philippe Lambin
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506. Molecular cancer therapeutics 20 (12) (2021)
Alexandra M Mowday, Ludwig J Dubois, Aleksandra M Kubiak, Jasmine V E Chan-Hyams, Christopher P Guise, Amir Ashoorzadeh, Philippe Lambin, David F Ackerley, Jeff B Smaill, Nigel Peter Minton, Jan Theys, Adam V Patterson
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours. Cancer gene therapy (2021)
Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, Alexandra M Mowday, Rituparna Mittra, Shevan Silva, Kevin O Hicks, Matthew R Bull, Victoria Jackson-Patel, Xiaojing Lin, Gareth A Prosser, Neil K Lambie, Gabi U Dachs, David F Ackerley, Jeff B Smaill, Adam V Patterson
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Dean C Singleton, Alexandra M Mowday, Chris P Guise, Sophie P Syddall, Sally Y Bai, Dan Li, Amir Ashoorzadeh, Jeff B Smaill, William R Wilson, Adam V Patterson
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit. Cancer gene therapy (2021)
Zhe Fu, Alexandra M Mowday, Jeff B Smaill, Ian F Hermans, Adam V Patterson
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy. Cells 10 (5) (2021)
Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Damiënne Marcus, Behzad Rezaeifar, Brigitte Reniers, Frank Verhaegen, Jan Theys, Ludwig J Dubois
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide. Cancers 12 (6) (2020)

Alexandra M Mowday.css-eqlu8i{font-size:small;padding-left:4px;} (Alexsandra Mowday)

Publication Activity (10 Years)

Top Topics

Top Venues

Alexandra M Mowday (Alexsandra Mowday)